Jonathan Moorman is an Infectious Disease physician affiliated with East Tennessee State University. OpenAlex indexes 174 publications with 5,976 citations (h-index 45); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
615 N State Of Franklin Rd
Johnson City, TN 376048209
Telephone
423-930-8337Provider last certified this registry record 23 Jan 2024.
Clinical trials
- Prevalence of HIV-associated Neurocognitive Disorders (HAND) in a School of Medicine HIV/AIDS Outpatient Clinic
Sponsor: East Tennessee State University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
- KLS-Martin L.P.Program year20241 payment
- KLS-Martin L.P.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
65.6%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor30.3%Tivicay65%Dovato20%Isentress15%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor20%Descovy88%Abacavir12%Part D<11 patients+ 5 more classes in this area
Cardiovascular
11.1%Statin4.4%Atorvastatin Calcium54%Pravastatin Sodium46%Part D<11 patientsACE inhibitor2.4%Lisinopril100%Part D<11 patients+ 2 more classes in this area
Nervous system
9.2%Other antidepressants4.4%Mirtazapine100%Part D<11 patientsAzaspirodecanedione derivatives2.4%Buspirone Hcl100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
9 NIH research awards on record, funded 2000–2026 per NIH RePORTER. The latest:
- COVID-19: Characterizing trained immune responses to COVID-19
James H Quillen Va Medical Center
FY2022I01BX005428
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Plasma biomarkers for systemic inflammation in COVID‐19 survivors
PROTEOMICS - CLINICAL APPLICATIONS
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Stephen Geraci, MD
East Tennessee State University
Chuanfu Li
East Tennessee State University
Sean Glasgow, MD
East Tennessee State University
Ryland Byrd, MD
East Tennessee State University
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”